- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01597336
Treatment of Abdominal Abscesses With or Without Fibrinolysis
February 3, 2015 updated by: Shawn St. Peter, Children's Mercy Hospital Kansas City
The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The hypothesis is that fibrinolysis of a abscess will shorten hospital stay compared to drainage alone.
Study Type
Interventional
Enrollment (Anticipated)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients under age 18 found to have an abscess in their abdomen related to perforated appendicitis that requires a drain either prior to or after appendectomy.
Exclusion Criteria:
- Patients with known immune deficiency per medical record review
- Patients with another condition affecting surgical decision making or recovery
- Patients with drain unable to be placed
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Saline only flush of abscess
Saline alone used to flush abscess
|
Thirteen ml of saline is used to flush abscess at time of drain placement and twice daily thereafter.
Other Names:
|
Experimental: Saline plus tPA flush of abscess
Saline plus tPA used for abscess flush
|
Thirteen ml of 10% tPA in saline at time of drain and twice daily thereafter.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of hospital stay
Time Frame: 1-2 weeks
|
Length of time required for meeting discharge criteria
|
1-2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
May 10, 2012
First Submitted That Met QC Criteria
May 11, 2012
First Posted (Estimate)
May 14, 2012
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
February 3, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11120126
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Abscess
-
The Hospital for Sick ChildrenTerminated
-
Hannover Medical SchoolBayerCompletedAbscess, Intra-AbdominalGermany
-
BayerCompletedAbscess, Intra-Abdominal | Secondary PeritonitisChina
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAbdominal AbscessTaiwan
-
Kaiser PermanenteGenentech, Inc.CompletedAbdominal Abscess | Pelvic AbscessUnited States
-
Paolo GoffredoUnknown
-
National Taiwan University HospitalCompleted
-
Kaohsiung Veterans General Hospital.BayerCompletedLiver AbscessTaiwan
-
Hospital Italiano de Buenos AiresUnknownLiver Transplant AbscessArgentina
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
Clinical Trials on Saline flush of abscess
-
TriHealth Inc.CompletedObstruction; Catheter, Infusion Catheter (Vascular) | Catheter; Complications (Indwelling Catheter)United States
-
Semmelweis University Heart and Vascular CenterCompletedStroke | Aortic Aneurysm | Aortic Diseases | Aortic Aneurysm, Thoracic | Aortic Arch AneurysmHungary
-
University of Texas Southwestern Medical CenterCompleted
-
TriHealth Inc.TerminatedObstruction; Catheter, Infusion Catheter (Vascular) | Catheter; Complications (Indwelling Catheter)United States
-
Chang Gung Memorial HospitalNot yet recruitingPort-a-cath Occlusion | Normal Saline | Heparin Lock
-
Yasser S Mostafa, MDFayoum University HospitalRecruiting
-
Menoufia UniversityCompletedCirculatory FailureEgypt
-
Cardiff and Vale University Health BoardCardiff Metropolitan UniversityCompletedNon-healing Wound | Pilonidal AbscessUnited Kingdom
-
North Western Research CollaborativeUnknown
-
University Health Network, TorontoUnknownThoracic Aortic Aneurysm | Stroke, Complication | Aortic Stenosis SymptomaticCanada